Fertility testing company Proov announced Tuesday that it has raised $9.7 million in Series A funding.
The round was led by Hambrecht Ducera Growth Ventures with participation from SteelSky Ventures, WCC Partners, LightShip Capital, GingerBread Capital and Portfolia.
WHAT THEY DO
In early 2020, Proov scored FDA clearance for its at-home urine test measuring pregnanediol glucuronide, which can...
Video-game therapy. Digital therapeutic maker Akili announced that its video-game-like therapy for children with ADHD, dubbed EndeavorRx, will now be available on Android devices. The prescription digital therapeutic is geared towards kids 8 to 12 who are diagnosed with ADHD.
The company scored an FDA De Novo for the product in 2020, making it the first game-based therapeutic with clearance. In...
At-home fertility test maker Proov is expanding its footprint to Europe after receiving CE marking for its ovulation-confirming test kit.
Proov’s ovulation testing kit got clearance by the FDA for sales in the U.S. last year. The test looks for Pregnanediol Glucuronide (PdG), a metabolite of progesterone produced in urine after ovulation. When elevated levels of PdG are detected in urine, it...
The U.S. Air Force has inked a $1.3 million deal with MFB Fertility in order to provide military members and their partners the former’s home fertility tests.
The Air Force’s AFWERX office will invest in Proov, an at-home ovulation test with FDA clearance. The test works by measuring Pregnanediol Glucuronide (PdG), the urine metabolite of progesterone, which is released by the ovary after...
Women’s health company Proov got the FDA green light for its at-home ovulation testing kit.
Users can send away for the kit and get test strips, which can determine the presence of progesterone metabolite PdG in urine, which is linked to a woman's ovulation cycle.
The test was developed to help women find out if they are ovulating on a regular basis.
In the spring, the company will roll out...
